Independence Day Special issue with Vivek Hattangadi tracing the India pharma brand story from before Independence till today.Read More
A diverse, summer issue with articles on topics ranging from content marketing to the role of experience in a VUCA world. Also, the latest book for Medical Reps reviewed by Prof. Vivek Hattangadi
Special issue, focusing on the generic versus branded debate that has opened up post the government mandate that Doctors should online prescribe generics.
Brand Building Special Issue with articles on personal branding, brand differentiation and avoiding brand arrogance
In this issue Deepak Sharma talks about his journey from Medical Rep to Country Manager. Deeksha Fouzdar presents a case study on implementation of a competency-based HR system in Pharma. Other articles by K. Hariram and Vivek Hattangadi
Guest Editorial by Sharadha Iyer on the urgent need to close the gender gap in the Indian Pharma Industry
2017 Learning and Development Special Issue. Articles by K. Hariram, Diksha Fouzdar and Vivek Hattangadi.
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha’s article is the highlight of this issue – an in-depth look at how to embed compliance in the very DNA of a pharma company.
K. Hariram reports on the OPPI 50th Annual General Meeting held in Mumbai on October 21. The report also features photos from the conference. Other topics covered include the role of emotions in pharma marketing, the importance in preparing much before-hand for the next level of your pharma career and the concept of the “tipping point” and its relevance for pharma marketing.
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.